Adverum Biotechnologies Inc. (NASDAQ: ADVM) Receives Orphan Drug Designation For ADVM-062

0
Adverum Biotechnologies Inc. (NASDAQ: ADVM) has announced that the US FDA has granted ADVM-062 Orphan Drug Designation. ADVM-062 is a proprietary gene therapy candidate...

DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

MAKE IT MODERN

LATEST REVIEWS

Best Stocks Alerts

Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...

0
In the ever-evolving landscape of biotechnology, certain milestones mark significant advancements in the fight against some of humanity's most persistent adversaries: cancer...

MAKE IT MODERN

PERFORMANCE TRAINING

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Micro and Macro Tailwinds Converge for KULR

0
We want to talk about what we believe to be an underappreciated stock right now: KULR Technology Group Inc. (OTCMKTS:KULR). But first, the context needs...

Inter & Co Inc (NASDAQ:INTR) bull rally may not subside and here’s why

0
Inter, a pioneering Brazilian company with its multifaceted "super app", has experienced a remarkable upward trajectory in its shares this year, sparking...

Wall Street Reporter Publishes Comments From Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix Inc (NASDAQ: BDSX),...

0
Wall Street recently published comments from the company CEOs of Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix Inc (NASDAQ: BDSX), Nova Mentis Life Sciences (OTCMKTS: NMLSF),...

REGENXBIO Inc. (NASDAQ:RGNX) Reports $98.9 Million in Q3 2020 Revenue Driven By Zolgensma Milestone...

0
REGENXBIO Inc. (NASDAQ:RGNX) has announced its financial results and corporate highlights for the three months ended September 2020. REGENXBIO received $80 Million in milestone payment...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد